DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

References

Kawanami D, Matoba K, Takeda Y. et al.
SGLT2 inhibitors as a therapeutic option for diabetic nephropathy.

Int J Mol Sci 2017;
18: 1083

Download Bibliographical Data

Search in: